Zdrowie i gospodarka · 05/05/2009

FDA Clarifies Regulatory Procedures for License Revocation Notifications

The Food and Drug Administration (FDA) is updating its procedures for notifying the public about the revocation of a biologics license to align with current practices, following the agency's direct final rule procedures. This change aims to provide a clear framework for handling potential comments on the revised rule.